drugset / Trial / NCT01896635

Faecal Microbiota Transplantation in Ulcerative Colitis

NCT01896635 ↗

Phase 2 Completed 81 enrolled The University of New South Wales
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether fecal microbiota transplantation (FMT) is safe and efficacious in the treatment of chronic active ulcerative colitis (UC) by conducting a randomised controlled trial

Timeline

Start
2013-11
Primary completion
2015-11
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator fecal microbiota transplantation Other / unclassified — —

Indications